Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma

Abstract excerpt

// Yasuo Takashima 1 , Yasushi Sasaki 2 , Azusa Hayano 1 , Jumpei Homma 3 , Junya Fukai 4 , Yasuo Iwadate 5 , Koji Kajiwara 6 , Shin Ishizawa 7 , Hiroaki Hondoh 3 , Takashi Tokino 8 and Ryuya Yamanaka 1 1 Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan 2 Center for Medical Education, Sapporo Medical University, Sapporo,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CNS Lymphoma Diagnosis and Treatment
• Share to Glioma Diagnosis and Treatment
• Share to Lymphoma Diagnosis and Treatment